Annette Tobia's Contact Details

Annette Tobia's Company Details

MEG21

N/A, , US • 20 - 49 Employees
Consumer Products

Born out of research at Fox Chase Cancer Center, MEG 21 focuses on glycation and inflammation as sources of oxidative stressors accelerating aging of the cells. MEG 21 products are clinically validated, cosmetically elegant and support healthy cellular function.Annette M. Tobia, Ph.D. started Dynamis almost 18 years ago, along with a team of scientists working at Fox Chase Cancer Center in Philadelphia, intent on discovering a treatment for diabetic complications, such as blindness and kidney disease.During the experimentation process, inspiration struck: Could a key to stopping the signs of aging be hidden in the treatment of diseases that we had been studying for most of our professional lives? To find an answer, we examined hundreds of other compounds and developed a dual nutrient formula, known now as MEG 21, which has proven to reduce the visible signs of aging.We rigorously tested the formula in more than seven independent clinical trials and over 150 volunteers, all of whom showed dramatic improvement in skin firmness, moisturization, smoothness, and reduction in fine lines.Years of research at Fox Chase Cancer Center in Philadelphia have resulted in the breakthrough skin product that is now yours. In addition to having at your fingertips a product uniquely able to remove toxic sugars from your skin, you will also find our staff singularly dedicated to providing you with best-in-class customer support.Welcome to our MEG 21 family and to healthier, younger skin.A portion of MEG 21 sales goes to cancer research. MEG 21 is a win-win for everyone in the family!